The change of CD4+ CD25high CCR6+ regulatory T cells in breast cancer patients

Journal of Sichuan University (Medical Science)

Volumn 41, Issue 3, 2010, Pages 415-419

  Xu, Lin ^a   Zhou, Ya ^a   Xiao, Dai Min ^a   Qin, Ming ^a   Luo, Jun Min ^a   Tang, Xian Ying ^a  

^a ZUNYI MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; CD4+ CD25high CCR6+ regulatory T cells; Tumor infiltration lymphocytes

Indexed keywords

CCR6 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR6; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PAGET NIPPLE DISEASE; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR ESCAPE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; RECEPTORS, CCR6; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE;

EID: 77953084524     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 1995;155(3): 1151-1164.
2. Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol, 2003;3(3): 189-198.
3. Von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat Immunol, 2005;6(4):338-344.
4. Joncker NT. Marloie MA, Chernysheva A, et al. Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors. Int J Cancer, 2006;118(5):1205-1214.
5. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med, 2005;353(25): 2654-2666.
6. high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J Surg Res, 2005;124 (1):151-157.
7. Lécureuil C, Combadière B, Mazoyer E, et al. Trapping and apoptosis of novel subsets of memory T lymphocytes expressing CCR6 in the spleen of HIV-infected patients. Blood, 2007;109 (9):3649-3657.
8. + T-cell subset. Blood, 2005;105 (7): 2877-2886.
9. + T lymphocytes in patients undergoing multiple course peptide vaccination. J Immunother, 2004;27 (1): 36-47.
10. Schmitz-Winnenthal FH, Volk C, Z'graggen K, et al. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Res, 2005;65 (21): 10079-10087.
11. Benigni F, Zimmermann VS, Hugues S, et al. Phenotype and homing of CD4 tumor-specific T cells is modulated by tumor bulk. J Immunol, 2005;175(2):739-748.
12. Gannage M, Abel M, Michallet AS, et al. Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia, implications for vaccine development and adoptive cellular immunotherapy. J Immunol, 2005;174(12):8210-8218.
13. + T cells confer superior antitumor immunity compared with effector memory T cells. PNAS, 2005;102(27):9571-9576.
14. Lamprecht B, Kreher S, Anagnostopoulos I, et al. Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. Blood, 2008;112(8):3339-3347.
15. Kerstin S, Markus F, Christiane S, et al. Migration matters, regulatory T-cell compartmentalization determines suppressive activity invivo. Blood, 2005;106(9):3097-3104.
16. + regulatory T cells subpopulation protects from lethal acute GVHD. Blood, 2005;105(5):2220-2226.
17. + regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med, 2007(204 (1):191-201.